🇺🇸 FDA
Patent

US 9649358

Methods for use of neural stem cell compositions for treatment of central nervous system lesions

granted A61KA61K35/30A61K38/18

Quick answer

US patent 9649358 (Methods for use of neural stem cell compositions for treatment of central nervous system lesions) held by The Regents of the University of California expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K35/30, A61K38/18, A61K38/185, A61P